Ardelyx Inc (ARDX): שווי כולל של נכסי החברה

Ardelyx, Inc. (ARDX) is a niche player in nephrology whose strategy relies on exclusive patents and the ability to independently determine therapy costs for insurers. This chart shows the market value of total assets reaching 521.54, confirming the company's financial foundation. High demand for Xphozah is driven by its unique phosphorus-blocking mechanism, making the drug indispensable. A rapid increase in prescriptions currently serves as the primary driver of revenue growth.

Total assets represent the aggregate of company resources, calculated reverse-engineered via ROA to eliminate quarterly reporting time lags and assess operational liquidity. By analyzing the trajectory of total balance sheet assets on GURU.Markets, an investor can evaluate the ability of Ardelyx, Inc. (ARDX) to scale the expansion of its unique nephrology-focused drugs into the dialysis market, balancing capitalization growth against the risks of frozen funds.